Julia Rincon-Gonzalez

Majadahonda, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 23, 2023

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

Journal: PloS one
Published: April 23, 2021

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.

Journal: Scientific reports
Published: July 27, 2020

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.

Journal: Haematologica
Published: March 21, 2019

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Journal: PloS one
Published: November 14, 2018

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia.

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia.

Journal: Scientific reports
Published: June 25, 2018

Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.

Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.

Journal: Hematological oncology
Published: June 07, 2018

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

Journal: British journal of haematology
Published: October 28, 2017

Mutational profile of primary breast diffuse large B-cell lymphoma.

Mutational profile of primary breast diffuse large B-cell lymphoma.

Journal: Oncotarget
Published: August 09, 2017

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Journal: Oncotarget
Published: August 02, 2017

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

Journal: PloS one
Published: January 09, 2017

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Journal: Haematologica
Published: August 22, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026